Cytokine Scaffold Builds Long-Lived CAR T Cells Against HIV

Published Date: 25 Jun 2026

A new approach aims to use CAR T cells to last longer in the fight against HIV.

Read Full News

Latest News

US Appeals Court Skeptical Of Bid to Curtail Abortion Pill Access

A U.S. appeals court on Wednesday appeared skeptical of a bid by the Republican-led state of Louisiana to curtail access to the abortion drug mifepristone by blocking a 2023...

Daily Probiotic Fails to Prevent Infections in Infants

Daily use of an oral probiotic from 6 to 24 months of age may not reduce the occurrence of ear or respiratory tract infections and antibiotic use in healthy infants.

Once-Monthly PrEP Drug Could Be Manufactured for $3 a Year

The current agreement manufacturer Merck has signed for global access to its once-monthly alimatravir would exclude countries with more than 230,000 new HIV acquisitions a year.

Testing for Duffy-Null Neutrophil Count Before Consult

By adding Duffy antigen testing to routine blood bank screens, VA identified 79 DANC patients, sparing many unnecessary bone marrow biopsies.

WHO Says Staff Shortage, Funding Challenges Hamper Congo Ebola Response

Shortages of trained staff, operational partners and funding are causing a bottleneck in efforts to expand the Ebola response in the Democratic Republic of Congo as the...

Lessons From Recent Viral Outbreaks

Despite advances in diagnostics and trial speeds, gaps in clinical care capacity, targeted therapies, and public communication threaten global preparedness for the next pandemic.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Latest News

A U.S. appeals court on Wednesday appeared skeptical of a bid by the Republican-led state of Louisiana to curtail access to the abortion drug mifepristone by blocking a 2023...

Daily use of an oral probiotic from 6 to 24 months of age may not reduce the occurrence of ear or respiratory tract infections and antibiotic use in healthy infants.

The current agreement manufacturer Merck has signed for global access to its once-monthly alimatravir would exclude countries with more than 230,000 new HIV acquisitions a year.

By adding Duffy antigen testing to routine blood bank screens, VA identified 79 DANC patients, sparing many unnecessary bone marrow biopsies.

Shortages of trained staff, operational partners and funding are causing a bottleneck in efforts to expand the Ebola response in the Democratic Republic of Congo as the...

Despite advances in diagnostics and trial speeds, gaps in clinical care capacity, targeted therapies, and public communication threaten global preparedness for the next pandemic.

News All Time

Measles Cases in Pennsylvania Rise to 460 Amid Ongoing Outbreak

Pennsylvania's health department said on Friday the confirmed number of cases linked to a measles ⁠outbreak has reached 460 this year, an increase of 36 over its update two...

More Than 6,000 People Infected With Ebola in Congo, Government Figures Show

The number of confirmed Ebola ⁠cases in the Democratic Republic of Congo has ⁠passed the 6,000 mark, government data ⁠showed on Monday.

US Widens Lettuce-related Cyclosporiasis Probe to 20 States

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce ⁠from central Mexico after detecting cases in three additional...

US FDA Approves Updated COVID Vaccines for 2026-27 Season

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi ⁠and Pfizer-BioNTech's updated COVID vaccines, the companies said on Thursday, ⁠after an advisory...

HIV Resistance Assay Offers Quick, Low-Cost Results for RTs

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including dolutegravir, a first-line drug with growing resistance.
HTTP error: 503

Dolutegravir ART Receives FDA Approval for Newborns With HIV

As the first second-generation INSTI approved for newborns with HIV, this approval allows for a simpler, more robust antiretroviral therapy regimen than existing standard of care.
HTTP error: 503HTTP error: 503

What’s Next for Lyme Disease Prevention?

HTTP error: 503

Orthostatic Hypotension: How to Diagnose and Manage

Aging alters autonomic regulation and raises orthostatic hypotension risk, making early recognition, appropriate testing, and individualized management essential in older adults.

As US Border Reopens to Mexican Cattle, Concerns Persist Over Screwworm Spread

Mexico is bolstering its screwworm containment campaign in northern border states where recent cases have been detected, heightening scrutiny of livestock exports as...

Nirsevimab Cuts Antibiotic Use for ARTIs in Infants

Nirsevimab use reduces antibiotic prescribing for acute respiratory tract infections in infants in both inpatient and outpatient settings.
HTTP error: 503

STI Rates Fall Two Thirds After Clinic Initiation of DoxyPEP

Real-world data revealed a high level of effectiveness on par with clinical trial data even among a high-risk population.

Recommended News For You

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

What is Mohs micrographic surgery? 8 FAQs about Mohs

Cancer detection recovered following pandemic disruptions

AI-based liquid biopsy shows promise for detecting brain cancer

Research exposes far-reaching toll of financial hardship on patients with cancer

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

X-ray and radar technology combined to reduce cancer screening risks

Recommended Articles For You

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care 

Emerging Therapies Using Combination Radiopharmaceutical Platforms for Sequential Tumor Targeting 

Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Beyond What Is Visible in Myelofibrosis?

2.

MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information

3.

ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology

4.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

5.

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

1.

Tumor Ecological Stability and Disease Course Evolution

2.

Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts

3.

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment

4.

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment

5.

Critical Care Updates on Hematopoietic Dysfunction During Prolonged Critical Illness

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

3.

Comprehensive Update on Hematology

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

5.

Efficient Management of First line ALK-rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot